Chemotherapy-induced Nausea and Vomiting
114
5
5
77
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Published Results
40 trials with published results (35%)
Research Maturity
77 completed trials (68% of total)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
5.3%
6 terminated out of 114 trials
92.8%
+6.3% vs benchmark
38%
43 trials in Phase 3/4
52%
40 of 77 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 77 completed trials
Clinical Trials (114)
Effect of Guided Imagery on Chemotherapy-related Nausea and Vomiting
Serious Gaming for Chemotherapy-induced Nausea and Vomiting
An Exploratory Study on Efficacy and Safety of Fosaprepitant and Palonosetron Hydrochloride for Injection in Preventing CINV From Multi-Agent HEC
Effect of Foot Reflexology On Chemotherapy Induced Nausea and Vomiting in Breast Cancer Patients
The Effect of Stress Ball on Nausea, Anxiety, and Fatigue in Patients With Stomach Cancer
NEPA Combined With Olanzapine, Dexamethasone-sparing for the Effect of CINV in Patients Receiving HEC Regimens
Stimulation of Acupuncture Points by Athermic Laser Therapy for the Prevention of Chemotherapy Induced Nausea and Vomiting in Children
A Prospective, Multicenter, Study of APF530 (Granisetron) SC for Prevention of CINV in Patients Receiving HEC
Oral Akynzeo® vs Standard of Care in Preventing CINV in High-risk MEC Patients (MyRisk)
To Evaluate the Efficacy and Safety of QLM2010 for Prevention of Chemotherapy-induced Nausea and Vomiting After Highly Emetogenic Chemotherapy.
Steroid-sparing Therapy (Olanzapine) Versus Dexamethasone-based Therapy for Chemotherapy-induced Nausea and Vomiting
Auricular Neurostimulation for Chemotherapy Induced Nausea and Vomiting
The Effects of Acupuncture and the Therapist´s Communication on Chemotherapy Induced Nausea and Vomiting
Olanzapine and 5-HT3 With or Without Dexamethasone to Prevent CINV
Aromatherapy for Chemotherapy-induced Nausea and Vomiting (CINV)
Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer
Safety of a Three-Day Fosaprepitant Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-045)
The Effect of Mandala Technique on Acute Nausea-vomiting and Comfort Level in Cancer Patients
Anti-emetic Prophylaxis With or Without Dexamethasone
To Study the Safety and Effectiveness of a Granisetron Patch to Treat Chemotherapy-Induced Nausea and Vomiting (CINV)